What are the limitations of the hct ci sorror score?

While the hct ci sorror score is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the hct ci sorror score to ensure safe bedside use and optimal diagnostic accuracy.

How does the hct ci sorror score compare to other Oncology scores?

The hct ci sorror score is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the hct ci sorror score free to use?

Yes. OpiCalc provides the hct ci sorror score completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

HCT-CI (Sorror Score)

Myeloma & MPN

Pre-transplant comorbidity index for hematopoietic cell transplantation.

Arrhythmia

Coronary artery disease

Diabetes

Obesity

Mild hepatic disease

Active infection

Psychiatric disturbance

Rheumatologic disease

Peptic ulcer history

Moderate pulmonary disease

Renal impairment

Prior solid tumor

Valvular heart disease

Severe pulmonary disease

Moderate or severe hepatic disease

Calculated Interpretation

Low Risk

0 Points

Lowest transplant comorbidity burden.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Pre-transplant comorbidity index for hematopoietic cell transplantation.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Arrhythmia

Coronary artery disease

Diabetes

Obesity

Mild hepatic disease

Active infection

Psychiatric disturbance

Rheumatologic disease

Peptic ulcer history

Moderate pulmonary disease

Renal impairment

Prior solid tumor

Valvular heart disease

Severe pulmonary disease

Moderate or severe hepatic disease

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Pre-transplant comorbidity index for hematopoietic cell transplantation.

OpiCalc Medical Oncology ModuleMyeloma & MPN2026

CLINICAL INSIGHT

Background

Context

HCT-CI (Sorror Score) is included in the oncology module as a structured decision-support tool for myeloma & mpn workflows.

No clinical reference data available.

HCT-CI (Sorror Score)

Myeloma & MPN

Pre-transplant comorbidity index for hematopoietic cell transplantation.

Arrhythmia

Coronary artery disease

Diabetes

Obesity

Mild hepatic disease

Active infection

Psychiatric disturbance

Rheumatologic disease

Peptic ulcer history

Moderate pulmonary disease

Renal impairment

Prior solid tumor

Valvular heart disease

Severe pulmonary disease

Moderate or severe hepatic disease

Calculated Interpretation

Low Risk

0 Points

Lowest transplant comorbidity burden.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Pre-transplant comorbidity index for hematopoietic cell transplantation.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Arrhythmia

Coronary artery disease

Diabetes

Obesity

Mild hepatic disease

Active infection

Psychiatric disturbance

Rheumatologic disease

Peptic ulcer history

Moderate pulmonary disease

Renal impairment

Prior solid tumor

Valvular heart disease

Severe pulmonary disease

Moderate or severe hepatic disease

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Pre-transplant comorbidity index for hematopoietic cell transplantation.

OpiCalc Medical Oncology ModuleMyeloma & MPN2026

CLINICAL INSIGHT

Background

Context

HCT-CI (Sorror Score) is included in the oncology module as a structured decision-support tool for myeloma & mpn workflows.

No clinical reference data available.